These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31933776)

  • 1. Exosomal miR-200 family as serum biomarkers for early detection and prognostic prediction of cholangiocarcinoma.
    Shen L; Chen G; Xia Q; Shao S; Fang H
    Int J Clin Exp Pathol; 2019; 12(10):3870-3876. PubMed ID: 31933776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma.
    Pan Y; Shao S; Sun H; Zhu H; Fang H
    Front Oncol; 2022; 12():985089. PubMed ID: 36091129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic potential of miR-200 family members in gingival crevicular fluid for chronic periodontitis: correlation with clinical parameters and therapeutic implications.
    Yu SL
    BMC Oral Health; 2023 Jul; 23(1):532. PubMed ID: 37525201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.
    Han HS; Kim MJ; Han JH; Yun J; Kim HK; Yang Y; Kim KB; Park SM
    Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):41-50. PubMed ID: 31784323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Exosomal miR-422a and miR-125b-2-3p Serve as Biomarkers for Ischemic Stroke.
    Li DB; Liu JL; Wang W; Li RY; Yu DJ; Lan XY; Li JP
    Curr Neurovasc Res; 2017; 14(4):330-337. PubMed ID: 28982331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease.
    Chen P; Huang S; Yu Q; Chao K; Wang Y; Zhou G; Zhuang X; Zeng Z; Chen M; Zhang S
    Gastroenterol Rep (Oxf); 2022; 10():goab056. PubMed ID: 35382172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
    Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
    J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas.
    Kim S; Choi MC; Jeong JY; Hwang S; Jung SG; Joo WD; Park H; Song SH; Lee C; Kim TH; An HJ
    J Cancer; 2019; 10(9):1958-1967. PubMed ID: 31205555
    [No Abstract]   [Full Text] [Related]  

  • 13. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
    Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
    Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
    Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of serum exosomal miR-23b-3p in non-small cell lung cancer and its diagnostic efficacy.
    Wang J; Xue H; Zhu Z; Gao J; Zhao M; Ma Z
    Oncol Lett; 2020 Oct; 20(4):30. PubMed ID: 32774503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200a-3p and GATA6 are abnormally expressed in patients with non-small cell lung cancer and exhibit high clinical diagnostic efficacy.
    Yu J; He X; Fang C; Wu H; Hu L; Xue Y
    Exp Ther Med; 2022 Apr; 23(4):281. PubMed ID: 35317445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.